Loading... Please wait...
App Store Download on the App Store Google Play GET IT ON Google Play

Evelo Biosciences, Inc. (EVLO) Ownership

Currency in USD Disclaimer
Add to Alerts
Add to Watchlist
$0.00 -$0.04 (-99.75%)
$0
$0.04
$0
$13.93

  • RECENT QUARTER TOTAL INVESTED

    $88,502

      $15,127.00

  • RECENT QUARTER INSTITUTIONAL OWNERSHIP PERCENTAGE

    0.4%

      0.38%

  • TOTAL INVESTED OF LAST QUARTER

    $73,375

  • OWNERSHIP PERCENTAGE OF LAST QUARTER

    0.02%
*Showing results of the last quarter update as of 09/30/2023

Evelo Biosciences, Inc. Major Shareholders & Ownership History

Reporting Date Major Shareholder Name Shares Held Market Value Change in Shares Ownership
11/14/2023 MAYO CLINIC 22,577 $88,502   0.00% 0.40%

Evelo Biosciences, Inc. institutional Ownership - Frequently Asked Questions

  • Q. Who are the largest shareholders of EVLO shares?

    A. During the previous two years, 5 institutional investors and hedge funds held shares of Evelo Biosciences, Inc.. The most heavily invested institutionals were:

    PARAMETRIC PORTFOLIO ASSOCIATES LLC: 36,221

    Amalgamated Financial Corp.: 4,945

    AMUNDI ASSET MANAGEMENT US, INC.: 32,472

    TEACHERS ADVISORS, LLC: 19,181

    TIAA CREF INVESTMENT MANAGEMENT LLC: 17,295

  • Q. What percentage of Evelo Biosciences, Inc. stock is owned by institutional investors?

    A. 0.40% of Evelo Biosciences, Inc. stock is owned by institutional investors.

  • Q. How much institutional buying is happening at EVLO ?

    A. Institutional investors have bought a total of 110,114 shares in the last 24 months. This purchase volume represents approximately $11 in transactions.

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In

or
Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Sign Up With Email Address
or
Continue with Google Continue with Apple

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.